Stay updated on Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.
Latest updates to the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page
- Check2 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.SummaryDifference0.1%
- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check38 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference1%
- Check45 days agoChange DetectedThe recent updates include the addition of two significant studies related to HIV-1 treatment, focusing on the efficacy of Dolutegravir compared to ritonavir-boosted lopinavir, and the mechanisms of integrase inhibitor resistance, while the previous entries have been removed.SummaryDifference7%
- Check53 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information have been removed.SummaryDifference2%
- Check60 days agoChange DetectedSeveral key health-related URLs have been removed, including links to MedlinePlus and PubMed articles, which may impact access to important medical information.SummaryDifference0.2%
Stay in the know with updates to Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.